NCT06451042View on ClinicalTrials.gov

FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)

RecruitingOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Glioblastoma Multiforme
Interventions
DIAGNOSTIC_TEST

FET-PET/MRI

Radiation planning target volume (PTV) when planned with FET-PET/MRI to PTV when planned with conventional (Standard of Care) MRI only. 0-(2-18F-Fluoroethyl)-L-Tyrosine (FET) 180-200 megabecquerel (MBq) administered intravenously prior to PET/MRI imaging.

Trial Locations (1)

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER